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We previously demonstrated by Western blotting and immunocytochemistry that 
a GnRH agonist (leuprorelin acetate, LA) was able to induce a post-transcriptional 
increase in GnRH receptor (GnRH-R) expression at the plasma membrane of andro-
gen-sensitive (LNCaP) and -insensitive (PC-3) prostate cancer (PCa) cells. In the pre-
sent study, we used atomic force microscopy (AFM) to gain a deeper insight into the 
eff ects of LA on the behaviour of GnRH-R in highly invasive and poorly diff erenti-
ated PC-3 cells. The use of this powerful, non-destructive technique allows to identify 
and study the biological features of the living cell surface, as ligand-receptor inter-
actions. Here, we investigated for 6, 12, 18, 24 and 30 days, the eff ect of LA (10-11 
and 10-6 M) in PC-3 cells on: i) amount of LA/GnRH-R binding events (i.e. GnRH-R 
quantifi cation), ii) strength of the analogue-receptor binding, iii) receptor topography. 
Brieﬂ y, analogue molecules were immobilized onto conical AFM tips and the single 
agonist/receptor interactions were measured by force-distance cycles.
In agreement with our previous results, the number of GnRH-R augmented dur-
ing 30 days due to the eff ect of LA treatment. The increasing rate of GnRH-R was 
dose-dependent until the 24th day and reached the maximum (~70%) after 30 days of 
treatment with the highest dose of LA (10-6M).
At least 2 diff erent receptor bound strengths have been detected, probably due to 
the presence of two GnRH-R classes. The majority of the sites showed a relatively 
low bound strength (~37 piconewton).
A LA/GnRH-R complex lifetime of ~ 9s and ~3.4 s for the higher and lower 
bound strength receptors, respectively, has been determined.
Regarding GnRH-R topography, a homogeneous distribution of the binding 
events has been found on untreated and LA-treated PC-3 cell surfaces.
The persistence of high receptor levels at the androgen-insensitive cell surface 
may warrant the maintenance of the response to the analogue in androgen-unrespon-
sive PCa also, which might be useful in clinical practice. Moreover, the defi nition of 
parameters as ligand/receptor bond strength and lifetime could shed light on the 
poorly understood molecular basis of LA/GnRH-R interaction and might be used to 
address structural/chemical agonist optimizations.
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